Organon and Forendo Pharma today announced that the companies have entered into a definitive agreement, under which Organon will acquire Forendo, a clinical-stage drug development company focused on novel treatments in women’s health. Forendo is pioneering the science of intracrinology, addressing disease through a novel, tissue-specific approach. Its lead clinical compound is an investigational, potentially first-in-class oral 17β-hydroxysteroid dehydrogenase type 1 (HSD17B1)…
Leading D2C postnatal care company, Mombox, announced today its acquisition of WellNested, a Boston-based technology solution company designed to help new parents find and book quality and affordable postnatal care services. Mombox plans to integrate the technology as part of its larger relaunch later this year. The terms of the acquisition were not disclosed. WellNested’s Chief Operating Officer, Karina Akib, will join Mombox to oversee the…
Pharmavite, the makers of Nature Made vitamins and supplements, announced today that it has acquired leading urinary health brand Uqora as part of its ongoing commitment to providing science-based solutions in the underserved women’s health market. Founded in 2017 by partners Jenna Ryan and Spencer Gordon, Uqora is a San Diego-based company addressing urinary health issues with a combination of reactive solutions and proactive care. Uqora…
CooperCompanies has announced the acquisition of obp Medical by CooperSurgical, one of its business units. obp Medical is a U.S. based medical device company that develops and markets differentiated products including single-use vaginal speculums with integrated LED illumination. Commenting on the transaction, Al White, Cooper’s President and CEO said, “This acquisition is a great strategic fit that builds upon CooperSurgical‘s strong family of OB/GYN…
Todos Medical, a comprehensive medical diagnostics and related solutions company, today announced that it has acquired Provista Diagnostics, Inc. Provista is a medical diagnostics company based in Alpharetta, Georgia that owns the intellectual property rights to the proprietary breast cancer blood test, Videssa, and has a diagnostic testing laboratory currently performing COVID-19 PCR testing, primarily for the medical and entertainment industries. The…
Pelvalon today announced reimbursement for the company’s Eclipse System under a new national payment established by the Centers for Medicare and Medicaid Services (CMS). The decision enables women access to a life-changing therapy for loss of bowel control, as well as the potential to reduce costs to the healthcare system compared to existing, more expensive treatments. Headquartered in Santa Clara, California, privately…
